AUPQ441499A0 – Novel compound
– Google Patents
AUPQ441499A0 – Novel compound
– Google Patents
Novel compound
Info
Publication number
AUPQ441499A0
AUPQ441499A0
AUPQ4414A
AUPQ441499A
AUPQ441499A0
AU PQ441499 A0
AUPQ441499 A0
AU PQ441499A0
AU PQ4414 A
AUPQ4414 A
AU PQ4414A
AU PQ441499 A
AUPQ441499 A
AU PQ441499A
AU PQ441499 A0
AUPQ441499 A0
AU PQ441499A0
Authority
AU
Australia
Prior art keywords
novel compound
novel
compound
Prior art date
1999-12-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ4414A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1999-12-02
Filing date
1999-12-02
Publication date
2000-01-06
1999-12-02
Application filed by Fujisawa Pharmaceutical Co Ltd
filed
Critical
Fujisawa Pharmaceutical Co Ltd
1999-12-02
Priority to AUPQ4414A
priority
Critical
patent/AUPQ441499A0/en
2000-01-06
Publication of AUPQ441499A0
publication
Critical
patent/AUPQ441499A0/en
2000-11-13
Priority to EP00974973A
priority
patent/EP1244669A1/en
2000-11-13
Priority to AU13093/01A
priority
patent/AU1309301A/en
2000-11-13
Priority to PCT/JP2000/008008
priority
patent/WO2001040230A1/en
2000-11-13
Priority to JP2001540985A
priority
patent/JP2003515537A/en
2000-11-14
Priority to ARP000106007A
priority
patent/AR026470A1/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 – C07D477/00
C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 – C07D477/00 in which the condensed system contains two hetero rings
C07D487/04—Ortho-condensed systems
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P11/00—Drugs for disorders of the respiratory system
A61P11/06—Antiasthmatics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P13/00—Drugs for disorders of the urinary system
A61P13/12—Drugs for disorders of the urinary system of the kidneys
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P19/00—Drugs for skeletal disorders
A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/04—Centrally acting analgesics, e.g. opioids
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
A61P25/16—Anti-Parkinson drugs
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/22—Anxiolytics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/24—Antidepressants
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer’s disease or other forms of dementia
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P3/00—Drugs for disorders of the metabolism
A61P3/04—Anorexiants; Antiobesity agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P3/00—Drugs for disorders of the metabolism
A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P37/00—Drugs for immunological or allergic disorders
A61P37/02—Immunomodulators
A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P7/00—Drugs for disorders of the blood or the extracellular fluid
A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/06—Antiarrhythmics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/12—Antihypertensives
AUPQ4414A
1999-12-02
1999-12-02
Novel compound
Abandoned
AUPQ441499A0
(en)
Priority Applications (6)
Application Number
Priority Date
Filing Date
Title
AUPQ4414A
AUPQ441499A0
(en)
1999-12-02
1999-12-02
Novel compound
EP00974973A
EP1244669A1
(en)
1999-12-02
2000-11-13
Pyrazolopyrazines and their use as adenosine antagonists
AU13093/01A
AU1309301A
(en)
1999-12-02
2000-11-13
Pyrazolopyrazines and their use as adenosine antagonists
PCT/JP2000/008008
WO2001040230A1
(en)
1999-12-02
2000-11-13
Pyrazolopyrazines and their use as adenosine antagonists
JP2001540985A
JP2003515537A
(en)
1999-12-02
2000-11-13
Pyrazolopyrazine and its use as adenosine antagonists
ARP000106007A
AR026470A1
(en)
1999-12-02
2000-11-14
A PIRAZOLPIRAZINE COMPOUND, PROCESS TO PREPARE IT, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND ITS PREPARATION, AND THE USE OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES.
Applications Claiming Priority (1)
Application Number
Priority Date
Filing Date
Title
AUPQ4414A
AUPQ441499A0
(en)
1999-12-02
1999-12-02
Novel compound
Publications (1)
Publication Number
Publication Date
AUPQ441499A0
true
AUPQ441499A0
(en)
2000-01-06
Family
ID=3818556
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AUPQ4414A
Abandoned
AUPQ441499A0
(en)
1999-12-02
1999-12-02
Novel compound
Country Status (5)
Country
Link
EP
(1)
EP1244669A1
(en)
JP
(1)
JP2003515537A
(en)
AR
(1)
AR026470A1
(en)
AU
(1)
AUPQ441499A0
(en)
WO
(1)
WO2001040230A1
(en)
Families Citing this family (14)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US20020115635A1
(en)
*
2001-02-21
2002-08-22
Pnina Fishman
Modulation of GSK-3beta activity and its different uses
AUPR548601A0
(en)
2001-06-06
2001-06-28
Fujisawa Pharmaceutical Co., Ltd.
Pyrazolopyrazinecompound and pharmaceutical use thereof
AUPR606401A0
(en)
*
2001-07-02
2001-07-26
Fujisawa Pharmaceutical Co., Ltd.
Pyrazolopyridine compound and pharmaceutical use thereof
WO2003039451A2
(en)
*
2001-11-08
2003-05-15
Fujisawa Pharmaceutical Co., Ltd.
Thiazole pyridazinones as adenosine antagonists
PT2942082T
(en)
2002-01-28
2019-06-06
Kyowa Hakko Kogyo Kk
A2a receptor antogonists for use in the treatment of movement disorders
GB0419192D0
(en)
2004-08-27
2004-09-29
Merck Sharp & Dohme
Therapeutic agents
WO2006038734A1
(en)
*
2004-10-08
2006-04-13
Astellas Pharma Inc.
Pyridazinone derivatives cytokines inhibitors
KR20080049758A
(en)
*
2005-09-01
2008-06-04
아스텔라스세이야쿠 가부시키가이샤
Pyridazinone derivatives used for the treatment of pain
WO2007040208A1
(en)
*
2005-10-03
2007-04-12
Ono Pharmaceutical Co., Ltd.
Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
ES2273599B1
(en)
2005-10-14
2008-06-01
Universidad De Barcelona
COMPOUNDS FOR THE TREATMENT OF HEADPHONE FIBRILATION.
ES2544869B2
(en)
*
2014-03-04
2016-01-18
Universidade De Vigo
Pyridazin-3 (2H) -one derivatives selective inhibitors of monoamine oxidase isoform B
AU2020240059A1
(en)
*
2019-03-20
2021-10-28
Goldfinch Bio, Inc.
Pyridazinones and methods of use thereof
JP2022533570A
(en)
*
2019-05-13
2022-07-25
リレー セラピューティクス， インコーポレイテッド
FGFR inhibitors and their uses
MX2022004739A
(en)
*
2019-10-31
2022-07-19
Holosmedic
Novel compound and pharmaceutical composition for prevention or treatment of cancer comprising same.
Family Cites Families (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB8901423D0
(en)
*
1989-01-23
1989-03-15
Fujisawa Pharmaceutical Co
Pyrazolopyridine compound and processes for preparation thereof
GB9015764D0
(en)
*
1990-07-18
1990-09-05
Fujisawa Pharmaceutical Co
Pyrazolopyridine compound and processes for preparation thereof
CN1046724C
(en)
*
1993-12-29
1999-11-24
藤泽药品工业株式会社
Novel compound
1999
1999-12-02
AU
AUPQ4414A
patent/AUPQ441499A0/en
not_active
Abandoned
2000
2000-11-13
WO
PCT/JP2000/008008
patent/WO2001040230A1/en
not_active
Application Discontinuation
2000-11-13
EP
EP00974973A
patent/EP1244669A1/en
not_active
Withdrawn
2000-11-13
JP
JP2001540985A
patent/JP2003515537A/en
not_active
Withdrawn
2000-11-14
AR
ARP000106007A
patent/AR026470A1/en
unknown
Also Published As
Publication number
Publication date
AR026470A1
(en)
2003-02-12
EP1244669A1
(en)
2002-10-02
JP2003515537A
(en)
2003-05-07
WO2001040230A1
(en)
2001-06-07
Similar Documents
Publication
Publication Date
Title
AU1278701A
(en)
2001-05-14
Novel compounds
AU5413600A
(en)
2001-01-02
Compounds
AU2001271434A1
(en)
2003-01-08
Novel skateboard-bicycle combination
AU732211C
(en)
2004-05-06
Novel compound
AU2408300A
(en)
2000-07-24
Novel compounds
AUPP999799A0
(en)
1999-05-20
New compound
AUPQ441499A0
(en)
2000-01-06
Novel compound
AU1746401A
(en)
2001-06-06
Compounds
AU6032100A
(en)
2001-01-02
New compounds
AU3997700A
(en)
2000-10-04
Anti-first-pass effect compounds
AU4132200A
(en)
2000-11-10
Novel compounds
AU2359301A
(en)
2001-06-04
Novel ss-defensins
AU2109700A
(en)
2000-08-07
Novel compounds
AU5787901A
(en)
2001-07-09
Compound
AU6567400A
(en)
2001-03-05
Substituted 2-imino-thiazolines
AU2288900A
(en)
2000-08-01
Novel compounds
AU5119400A
(en)
2000-12-18
Compounds
AU1385701A
(en)
2001-05-08
Novel compounds
AU4156800A
(en)
2000-10-09
Novel compounds
AU7784700A
(en)
2001-04-30
Novel compounds
AU6168900A
(en)
2001-02-05
Compounds
AU2668000A
(en)
2000-08-29
Bis-styrylbiphenyl compounds
AU2985200A
(en)
2000-08-25
Novel sialoadhesins
AU2194201A
(en)
2001-06-25
Novel compound
AUPP377198A0
(en)
1998-06-18
Novel compound WF00144
None